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Abstract
Background: Liver Regeneration is clinically of major importance in the setting of liver injury, resection or transplantation.
We have demonstrated that the NF-kB inhibitory protein A20 significantly improves recovery of liver function and mass
following extended liver resection (LR) in mice. In this study, we explored the Systems Biology modulated by A20 following
extended LR in mice.
Methodology and Principal Findings: We performed transcriptional profiling using Affymetrix-Mouse 430.2 arrays on liver
mRNA retrieved from recombinant adenovirus A20 (rAd.A20) and rAd.bgalactosidase treated livers, before and 24 hours
after 78% LR. A20 overexpression impacted 1595 genes that were enriched for biological processes related to inflammatory
and immune responses, cellular proliferation, energy production, oxidoreductase activity, and lipid and fatty acid
metabolism. These pathways were modulated by A20 in a manner that favored decreased inflammation, heightened
proliferation, and optimized metabolic control and energy production. Promoter analysis identified several transcriptional
factors that implemented the effects of A20, including NF-kB, CEBPA, OCT-1, OCT-4 and EGR1. Interactive scale-free network
analysis captured the key genes that delivered the specific functions of A20. Most of these genes were affected at basal level
and after resection. We validated a number of A20’s target genes by real-time PCR, including p21, the mitochondrial solute
carriers SLC25a10 and SLC25a13, and the fatty acid metabolism regulator, peroxisome proliferator activated receptor alpha.
This resulted in greater energy production in A20-expressing livers following LR, as demonstrated by increased enzymatic
activity of cytochrome c oxidase, or mitochondrial complex IV.
Conclusion: This Systems Biology-based analysis unravels novel mechanisms supporting the pro-regenerative function of
A20 in the liver, by optimizing energy production through improved lipid/fatty acid metabolism, and down-regulated
inflammation. These findings support pursuit of A20-based therapies to improve patients’ outcomes in the context of
extreme liver injury and extensive LR for tumor treatment or donation.
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Introduction
Among the viscera the liver has the unique capacity to
regenerate following liver resection (LR), or liver injury. The
mechanisms involved in this highly orchestrated repair process
have been extensively studied in humans undergoing LR, and
following liver transplantation or liver donation; and in animal
models of partial hepatectomy (PH) [1]. Both directed studies and
transcriptome-based approaches have demonstrated that the early
regenerative phase is marked by rapid hepatocyte proliferation
that usually occurs at the expense of a partial impairment of the
liver metabolic function [2,3,4].
Liver regeneration or more precisely its ‘‘compensatory’’ growth
is a complex process that comprises three main stages: transition of
the quiescent hepatocyte into the cell cycle (priming); progression
beyond the restriction point into the G1 phase of the cycle; and
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17715regulation of liver mass by apoptosis of excess hepatocytes in order
to restore optimal liver mass/body mass ratio. In optimal priming
and cycling conditions, it is the concerted activation of a
transcriptional network including NF-kB, STAT-3, AP-1, C/
EBP and peroxisome proliferator activated receptor (PPARa) that
enables the up-regulation of all genes necessary for the restoration
of a normal liver mass and function [5,6,7]. More than 70 genes
are associated with liver regeneration including immediate, early
genes (c-fos, c-jun,junB, c-myc), regulators of apoptosis (bcl-xL,
MAPK, JNK); cell cycle (Cyclins, CDK, CDKI), and inflamma-
tory and oxidative response genes (SOCS3, SOD and HO-1)
[2,3,8,9]. The expression of immediate early and delayed genes in
liver regeneration does not lead to DNA replication unless cells
can progress through the cell cycle following stimulation with
growth factors, including Epithelial Growth Factor (EGF),
Transforming Growth Factor b (TGFb) and Hepatocyte Growth
Factor (HGF) [10].
In order to maintain life, the regenerating liver must still
support, even if partially, the metabolic demands of the host and
provide for some liver synthetic function. Accordingly, a minimal
‘‘healthy’’ remnant liver mass is required to achieve these tasks.
Experimentally, a 66–70% LR is always well tolerated in mice and
rats. However extended (78%) or radical (87–90%) LR have a
50% and 100%, mortality rate, in mice [11,12]. Also, the usually
safe 66% LR in healthy mice is plagued with significant lethality
when performed on livers with underlying metabolic disease, such
as in PPARa-/- and Leptin or Leptin-receptor deficient mice
[13,14]. Similar issues are encountered in patients, where it is
widely appreciated that recovery of liver mass following hepatec-
tomy requires a metabolic compromise between differentiated
function and organ re-growth. Accordingly, in clinical settings,
hepatic failure after resection is more common when the organ is
diseased such as in livers suffering from severe steatosis, or in small
for size liver grafts [15].
Our aim over the past few years was to unravel novel
therapeutic targets that would promote liver regeneration and
function, and hence improve outcome of marginal and small for
size liver grafts, and allow for safer extended liver resection in
patients with large hepatic tumors. We have identified the NF-kB
dependent and NF-kB-inhibitory [16,17,18], ubiquitin-editing
protein A20/tnfaip3 [19] as a critical cytoprotective gene in the
liver. A20 is induced in hepatocytes in response to inflammatory
insults or injury, including liver resection, as part of a negative
regulatory feedback loop aimed at re-establishing homeostasis
[11,20,21]. A20 knockout mice are born cachectic and die within
3 weeks of birth as a result of unfettered inflammation in several
organs, including the liver [22], which indicates the importance of
A20 in the physiologic anti-inflammatory response, particularly in
hepatocytes. To complement this, we have shown that overex-
pression of A20 in the liver protects mice from toxic hepatitis
induced by D-galactosamine/lipopolysaccharide [21], fulminant
hepatic failure following extended (78%) or radical (87%) LR [11],
and severe liver ischemia/reperfusion injury [23]. The survival
advantage afforded by A20 in these models of extreme liver injury
relates to A20’s ability to limit inflammation by down-regulating
NF-kB activity, to inhibit TNF-induced apoptosis [21], to
accelerate hepatocyte proliferation by decreasing transcription of
the Cyclin-Dependent Kinase Inhibitor (CDKI) p21 [11,22], and
to protect hepatocytes from oxidative stress by increasing PPARa
expression [23]. Given the central role of A20 in liver regeneration
and repair, we set to explore, using a transcriptome-based
approach, the critical pathways and gene networks that are
modulated by A20 following extended (78%) LR that best models
extensive liver resection in patients.
Results
Transgene Expression in mouse livers prior to resection
Expression of A20 and the b-galactosidase (bgal) transgenes in
the mouse liver was achieved by penile vein injection of 1x10
9 pfu
of rAd. in 100 mL of normal saline, which results in optimal
expression 5 days after injection in 30% to 40% of hepatocytes, as
demonstrated by either Xgal staining, as described [21], or
quantitative real time PCR (qPCR) that was performed in all
tested samples to check for expression of human A20 and E. Coli
bgalactosidase transgenes (Fig. S1 A). All LR were accordingly
performed 5 days following rAd. injections (Fig. S1 B).
Response to resection dominates transgene effect in
influencing the overall transcriptome
We performed an unsupervised analysis of the microarray data in
orderto determine therelationship betweensamples and duplicates,
and the effect of A20 overexpression and resection on global
transcript expression (Fig. S2). By principal component analysis, we
demonstrated that samples separated on the basis of resection status
along primary component (PC) 1, which accounted for 47% of the
variation between samples. On the other hand, the transgene effect
was plotted along PC2, and accounted for 26% of the variation. We
also performed hierarchical clustering using a Pearson correlation
distance metric (Fig. S2, inset dendrogram), and demonstrated that
sample similarity was strongly based on resection status. Impor-
tantly, all biological replicates clustered together.
A20 modulates qualitative and quantitative transcript
expression both at the basal state and in response to
liver resection
As stated in the methods, a given gene was considered
differentially expressed, if 90% lower confidence bound (LCB) of
the fold change (FC) between the two groups was above 1.5 [24].
LCB is a stringent estimate of FC and is considered to be a better
ranking statistic [24,25]. We identified a total of 1, 595 unique
genes that met this criterion in at least one of the following
comparisons: rAd.b gal after resection (post-bgal) vs. rAd.bgal
before resection (pre-bgal) (541 genes), rAd.A20 after resection
(post-A20) vs. rAd.A20 before resection (pre-A20) (457 genes),
rAd.A20 before resection (pre-A20) vs. rAd.b-gal before resection
(pre-bgal) (531 genes), or rAd.A20 after resection (post-A20) vs.
rAd.b-gal after resection (post-bgal) (548 genes). Of the 1,595
genes, 402 were differentially expressed in more than one
condition (Fig. 1; Table S2).
When using gene clustering and self-organizing maps (SOM) to
detect groups of differentially expressed genes with similar
expression patterns, we arbitrarily drew 100 separate maps
according to Pearson correlation coefficient based distance metrics
(data not shown). Evaluation of the maps showed significant
similarity in the structure of many of the expression patterns,
which allowed us to reduce the number of distinct expression
profiles from 100 to 14 (Fig. 2). Gene expression patterns in which
A20 altered the basal levels (group C), the final levels (group H),
both basal and final levels (group I), basal levels but not the
response to resection (group F), and the response to resection but
not basal levels (group E), were identified (Fig. 2).
Analysis for functional enrichment by GO overrepresentation in
co-expressed gene clusters demonstrated significant (Benjamini-
Hochberg adjusted P-value 0.05) enrichment in 6 of the 14 clusters
(Table S3). Most notably, we noted enrichment for acute-phase
response (group A), immune and defense responses (group G), and
oxidation/reduction genes (groups E and P).
A20 Modifies the Liver Transcriptome
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function and recovery from injury
In order to better understand how A20 was affecting liver
regeneration, we narrowed the list of differentially expressed genes
to focus on those genes that were changing as a result of A20
overexpression, i.e. genes that met the following criteria: after
resection LCB $ 1.5, or before resection LCB $ 1.5, or A20 LCB
$ 1.5 and bgal LCB not $ 1.5. We assessed GO enrichment of
the A20 interacting genes by using BiNGO, a Cytoscape plugin
which maps significantly enriched GO terms onto a visual
representation of the GO hierarchy [12,26,27]. Our results
demonstrated a significant enrichment (Benjamini-Hochberg
adjusted P-value , 0.05) in all 3 categories of GO terms: cellular
component, molecular function, and biological process (Fig. S3).
In particular, the enrichment analysis demonstrated that A20
significantly affected cell cycle, as well as immune, and regulatory
processes that are important for liver proliferation in response to
injury. A20 overexpression in the liver also enriched for
oxidoreductase and electron carrier activity, as well as oxidation-
reduction processes, which highly, suggests that A20 impacts the
ability of the liver to produce energy and handle oxidative stress.
A20 overexpressing liver were also enriched for genes involved in
amino acid, fatty acid, steroid, and cholesterol biosynthesis,
indicating that A20 primarily modulates the liver biosynthetic
and metabolic processes.
Additionally, we probed for canonical pathways enrichment
using the Ingenuity Pathway Analysis (IPA) tools and calculated
the multiple test adjusted P-value for each pathway according to
the fit of user’s data to IPA database. This analysis confirmed a
significant enrichment in genes involved in several biosynthetic
and metabolic pathways, as well as acute phase response and
Figure 1. Venn diagram analysis on A20 modulated genes. Venn diagram showing the overlap among genes identified in any of the following
comparisons: i) rAd.bgal after vs. before resection (b-gal post vs. pre), ii) rAd.A20 after vs. before resection (post-A20 vs. pre-A20), iii) rAd.A20 before
resection vs. rAd.b gal before resection (pre-A20 vs. pre-bgal), or iv) rAd.A20 after resection vs. rAd. bgal after resection (post-A20 vs. post-bgal).
doi:10.1371/journal.pone.0017715.g001
Figure 2. Transcriptional changes induced by A20 at the basal
level and following liver resection. Self-organizing map (SOM)
analysis representing the different expression patterns. Genes are
selected using supervised analysis on the basis of LCB of the fold
change (FC) in the following groups: ‘‘bgal before resection [pre-bgal-1
and pre-bgal-2]’’, ‘‘bgal after resection [post-bgal-1 and post-bgal-2]’’,
‘‘A20 before resection [pre-A20-1 and pre-A20-2]’’ and ‘‘A20 after
resection [post-A20-1 and post-A20-2]. SOM clustering is performed on
the 1,595 genes obtained after analysis of the genes that were
differentially expressed among the four possible groups mentioned
above (Informative genes analysis section in methods). To understand
the biological theme of SOM patterns, Gene Ontology (GO) analysis was
performed on each pattern, and identified a number of genes that
regulated various interesting biological processes.
doi:10.1371/journal.pone.0017715.g002
A20 Modifies the Liver Transcriptome
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17715inflammatory signaling (Fig. 3). In keeping with the well-described
anti-inflammatory properties of A20, antigen presentation,
interferon signaling, and acute phase response pathways showed
an overall down-regulation of relevant transcripts. At the same
time, the bulk of genes involved in metabolic pathways were
upregulated by A20. Close examination of these metabolic
pathways suggested that A20 overexpression enhanced the activity
of these pathways, even after extended LR. These pathways being
central to the metabolic function of the liver, this suggests that A20
overexpression not only enhances the liver’s synthetic and
metabolic functions, but also preserves these functions during
the proliferative phase of liver regeneration, when they are usually
down-regulated as a result of energy shunting.
A20 impacts key nodes within inflammation, metabolism,
energy production, and proliferation networks before
and following extended liver resection
Network analysis with IPA software was used to analyze the
functional networks of the interacting genes and to identify the key
nodes within these networks. Scale free networks were constructed
based on the physical or regulatory interaction between genes or
gene products. Our results showed a significantly enrichment of
networks controlling cellular proliferation (Fig. 4A), energy
production (Fig. 4B), inflammation (Fig. 4C), and metabolic
functions (Fig. 4D), mirroring the result of the GO analysis. We
merged the top 15 networks to create an overall system-wide
Figure 3. Analysis of pathways enriched by A20 overexpression. Each Bar represents a significantly enriched pathway as determined using
the Benjamini-Hochberg hypothesis corrected P value (shown on primary X-axis). The directionality of the genes in each pathway is depicted using a
pseudocolor (red for upregulated genes, green for downregulated genes and white for unmodified genes). The total numbers of genes in each
pathway are shown on the secondary X-axis. The analysis for canonical pathways was performed using Ingenuity Systems.
doi:10.1371/journal.pone.0017715.g003
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PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e17715Figure 4. Network representation of the cellular functions supporting the effects of A20 overexpression. Networks shown: A) Cellular
proliferation related genes with CDKN1A and CDK2 as primary regulatory nodes; B) Genes involved in energy production and small molecule
biochemistry, such as SLC25A10 and SLC25A13; C) Inflammatory disease and immune response related genes with IFNc as a critical regulatory node;
and D) Genes involved in lipid and carbohydrate metabolism as well as oxidoreductase activity, with PPARa representing the dominant node. We
used the Ingenuity Pathways Analysis tool (www.ingenuity.com) to generate the networks of genes influenced by A20 overexpression, and merged
the major networks with obvious related functions. The intensity of the node color indicates the degree of up-regulation (red) and down-regulation
(green), while white nodes indicate non-modified genes that may be affected in a non-transcriptional manner. All networks shown were significantly
affected by A20 overexpression, with a score .10. The gene classes are represented by different symbols, as we depict in the attached legend.
doi:10.1371/journal.pone.0017715.g004
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and included the following molecules: CDKN1A (p21), RB1,
CDK2, TGFBR1, CyclinA, PPARa, AP1, and IFNc. While the
individual fold changes of these molecules were not necessarily
always significant, their centrality within the networks indicated
that they were key modulators of A20’s effects on liver
regeneration.
A limited, set of promoters is enriched in A20-expressing
livers following extended resection
We analyzed the promoter regions of genes within each of the
highly enriched networks for the presence of over-represented
transcription factor binding sites. Putative transcription factor
binding sites were identified in each network based on a .2 fold
enrichment (yes set versus no set) and on a P-value from a one-
tailed Fisher’s exact test .0.05 (Fig 5). We estimated the
importance of each transcription factor by calculating the number
of differentially regulated genes within each network that
contained a putative binding site for this transcription factor.
Based on this analysis, we identified a total of 21 putative
transcription factors, with 6 of them found in more than one
network (NF-kB, HSF2, CIZ, HNF1, IRF2, and OCT4). NF-kB,
the central target of A20 [28,29], was the only transcription factor
common to all 4 networks analyzed including cell cycle, energy
production, inflammation, and metabolic processes (Fig. 4).
However, other than in the cell cycle network, where it had the
greatest fold enrichment, NF-kB did not rank first in any of our
significance metrics in the other networks, indicating a relatively
small (even if broad and key) number of genes affected by NF-kB.
The lipid metabolism and inflammation networks shared 2
transcription factors (IRF2 and OCT4), whereas the cell cycle
and inflammation networks shared one transcription factor
(HSF2), as did cell cycle and lipid metabolism (CIZ), and energy
and lipid metabolism (HNF1). In the inflammation network 3
separate serum response factor (SRF) binding matrices met our
selection criteria, highlighting the likely involvement of SRF in
mediating A20’s effects on liver regeneration.
A20 modulates the expression of genes that are key to
the liver’s regenerative capacity
In order to determine how A20 affects an externally validated
set of key genes involved in liver regeneration, we interrogated a
previously published signature set of genes detailing the liver
transcriptome response 24 hrs following liver resection [30]. CEL
files were obtained from the Gene Expression Omnibus at the
National Institutes of Health (http://www.ncbi.nlm.nih.gov/geo/)
and processed with dChip, as outlined in the methods section. We
identified a seed set of 157 genes that peaked or showed a nadir in
their expression at 24 hrs and had an absolute LCB $ 2 from 0 to
24 hrs. When multiple probe sets existed for the same gene, the
probe set with the larger LCB was used. By network analysis and
after merging overlapping networks, we identified Key nodes by
their edge density. We included all constituent sub-units and
transcript variants, which helped us picking a set of 99 transcripts
(93 of which mapped back to the microarray) that represented the
24 hrs liver regeneration signature.
We did hierarchal clustering using a correlation-based metric
Pearson test, and rendered heat maps using standardized LCB
values for the regeneration signature, the rAd.bgal and the
rAd.A20 treated livers. The gene transcript profile was most
similar between rAd.A20 treated livers and the regeneration
signature, indicating that A20 overexpression compensated for any
detrimental effects of viral transduction. These results highlight the
fact that recombinant adenovirus transduction differentially
impacts liver regeneration, and stresses the importance of using
rAd.bgal transduced, rather than non-transduced livers, as a
control group in our study.
Clustering based on the magnitude of the response of specific
transcripts to resection (LCB) showed distinct sets of genes.
Clusters I-b and III-a related to genes whose behavior was altered
as a result of adenoviral transduction in control rAd.bgal
transduced livers but not rAd.A20 overexpressing livers, indicating
the ability of A20 to protect from adenoviral toxicity. Clusters I-a
and III-b, represented genes that distinguished both of our sets of
animals from the seed set; these likely represent differences relating
to mouse strain (Balb/c versus C57BL/6), adenoviral effects that
could not be compensated for by A20, and/or the extent of liver
resection (78% versus 66%).
We identified two key gene expression clusters that were
modified by A20 (Fig. S5). A20 upregulated the expression of a
subset of signature liver regeneration genes, even prior to resection
(Fig. S5 B), including many of the RNA polymerase subcompo-
nents, indicating that the cells are ready to engage in cell
replication. These genes were not subsequently upregulated
following resection, as they had already fulfilled their regenerative
Figure 5. Regulatory analysis of over-represented transcription
factor-binding sites (TFBS) based on the genes affected by A20
overexpression. Significantly enriched TFBS were determined by
promoter analysis of genes that were affected by A20 within the
following networks: cell cycle, energy production, inflammation and
immune system related, and lipid and carbohydrate metabolism. The
number of genes impacted by a given transcription factor are reflected
by the node size and statistical enrichment (P value), using a color scale
(red for highest enrichment and blue for no enrichment). P values were
derived from Fisher Exact test. The TFBS analysis was performed using
ExPlain 3.0 (http://explain.biobase-international.com/) for detection of
over-represented transcription factor binding sites. The analysis was
performed on 2000 bp upstream to 100 bp downstream of the
transcription start site of each gene.
doi:10.1371/journal.pone.0017715.g005
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regulated the basal expression of a subset of signature genes that
are usually only down-regulated upon liver resection, such as genes
involved in MAP-kinase signaling and cytokine and growth factor
responses, Many of these genes returned to their basal levels within
24 hours of liver resection, indicating that their rebound was
accelerated in A20 overexpressing livers.
In vivo validation of target genes and functional
enrichment
Key genes forming focus hubs within significantly modulated
interaction networks from, GO groups and canonical pathways
were selected for in vivo validation. Using qPCR, the expression of
CDKN1A (p21), PPARa and its target gene the mitochondrial
enzyme Carnitine Palmytyol Transferase 1 (CPT1a) [31], the
mitochondrial solute carrier genes SLC25A10 and SLC25A13, as
well as the IFNc target gene Ubiquitin D (UBD), were measured
in all samples (Fig. 6A). CDKN1A/p21 levels demonstrated
significant changes in expression before and 24 hrs after resection,
as compared to rAd.bgal controls: while both rAd.A20 and
rAd.bgal treated livers underwent significant up-regulation of p21
levels in response to resection, rAd.A20 livers had significantly less
p21 expression to start with, and as a result continued to have
significantly lower levels following resection, as demonstrated by
qPCR (Fig. 6A). These results suggest that A20 overexpressing
hepatocytes were pre-primed to proliferate. At the protein level by
immunohistochemisty, we showed significantly less nuclear p21
immunostaining at baseline in rAd.A20 treated livers, as compared
to rAd.bgal treated controls, which conversely translated in
significant increase of proliferating hepatocytes, as indicated by
the number of Ki67 positive cells in rAd.A20, as compared to
rAd.bgal treated livers, 48 hrs after resection (Fig. 6B). At that
time, i.e. 48 hrs following resection, p21 protein levels had
significantly decreased in rAd.bgal expressing livers of the animals
that had survived the surgery, indicating delayed regeneration was
about to proceed. Hepatocyte proliferation started by day 4 to 7
after 78% LR in rAd.bgal expressing livers, as indicated by Ki67
staining (data not shown), and as reported in other models of
delayed liver regeneration [32]. Since we have not measured p21
mRNA at 48 hrs after LR, we do not know if this is related to
Figure 6. validation of A20 target genes in hepatocytes. A) qRT-PCR was performed on mouse liver samples harvested before and 24 h after
extended LR. Graph represents the statistical analyzes of relative mRNA levels after normalization by bactin. Results are expressed as mean 6 SEM of
4–6 animals. P values were calculated by using 2-way ANOVA for resection, transgene, and the interaction. P values were listed under the graph.
Differences were considered significant when P,0.05. B) Representative photomicrographs showing decreased p21
waf1 positive cells in liver samples
transduced with recombinant adenovirus (rAd.)A20, as compared to control rAd. bgalactosidase (bgal) before resection and increased Ki67 staining
48 hrs after LR. Graph shows quantification of positive nuclei per high power field. Each bar represents the mean6SE from 4–6 different animals.
Original magnification, X400. ***p,0.001. C) Representative photomicographs showing increased COX activity in saline, rAd.A20 and rAd. bgal
transduced liver tissues 24 hrs following 78% LR. Graph shows scores of COX activity staining per high power field. Each bar represents the mean6SE
from 4–5 different animals. *p,0.05. D) Representative Oxyblot of rat primary hepatocytes transduced with rAd.A20 or rAd. bgal control adenovirus
for 48 h and exposed to 60 minutes hypoxia (1% O2) followed by 120 minutes reoxygenation. Cell lysates were immunoblotted for the detection of
carbonyl groups (n=3).
doi:10.1371/journal.pone.0017715.g006
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transcriptional or post-translational block in p21 expression. In
contrast, p21 protein levels were higher in rAd.A20 expressing
livers 48 hrs following LR as expected in livers that had undergone
sufficient regeneration and needed to stop the proliferative process
[33] (Fig. 6A).
A20 overexpression also resulted in significant up-regulation of
PPARa mRNA levels in mouse livers at baseline, and prevented
their down-regulation following extended LR, as demonstrated by
qPCR (Fig. 6A). We checked that PPARa was functional in the
system by showing that its upregulation translated into a significant
increase in carnitine palmytoyl transferase 1a (CPT1a) mRNA
(qPCR), a transcriptional target of PPARa and critical metabolic
regulator of fatty acid (FA) metabolism, both before and after 78%
LR (Fig. 6A).
PPARa is known to promote a net bioenergetics gain in the cells
through promoting mitochondrial ATP production. Accordingly,
we checked for cytochrome c oxidase (COX), i.e. mitochondrial
oxidation phosphorylation (OXPHOS) complex IV, activity in
saline, rAd.A20 and rAd.bgal treated livers 24 hours following LR,
by means of an enzymatic histology method, as described in the
methods section. Our data indicate that A20 overexpressing livers
show a significant increase in mitochondrial cytochrome c oxidase
activity in the liver post LR, a direct indication of enhanced energy
production in these organs (Fig. 6C, n=4–5 animals per group;
p,0.05).
PPARa being also an important modulator of the response to
oxidative stress and lipid peroxidation, oxidoreductase activity and
oxidation/reduction processes were both significantly enriched in
our gene ontology (GO) analysis. In order to validate this finding
and determine the net directionality of A20’s effect, we performed
OxyBlots on whole cell lystate from primary derived rat
hepatocytes that were subjected to 60 min. of hypoxia, followed
by 120 min. of reoxygenation, as a way to in vitro model the
oxidative stress imposed on hepatocytes, such as in the setting of
LR or ischemia reperfusion injury. Equal amounts of proteins
were carefully loaded in the gels, then analyzed for protein
oxidation. Our results showed decreased protein oxidation in
rAd.A20-transduced hepatocytes relative to either non-transduced
or rAd.bgal transduced hepatocytes, both immediately following
hypoxia and 2 hours after reoxygenation (Fig. 6D). Combined
with the GO process and function enrichment data, such in vitro
validation argues for a novel anti-oxidant affect of A20, that we
had demonstrated to be, least in part, PPARa-dependent [23].
Additionally, a number of mitochondrial carrier genes that
shuttle a variety of metabolites across the inner mitochondrial
membranes were also up-regulated in A20 overexpressing livers, as
determined by qPCR of mouse liver RNA before and after 78%
LR (Fig. 6A). These include mitochondrial solute carrier family 25
members 10 (Slc25a10), referred to as dicarboxylase carrier (DIC),
and SLC25 member 13, referred to as Aspartate Glutamate
Carrier (AGC2) or Citrin [34]. Both these proteins are involved in
lipid and glucose metabolism, contributing to increasing the
energy supply required for cellular functions.
By qPCR we also demonstrated that overexpression of A20 in
the liver significantly abrogated the upregulation of the leptin
receptor following 78% LR (Fig. 6A). The significance of this
finding is being explored.
We also determined that Interferon signaling was significantly
affected by A20 overexpression in the liver, with type II Interferon
(IFNc) being a significant node. Although IFNc levels per se were
not affected, IFNc target genes were significantly down-regulated
in rAd.A20, as opposed to rAd.bgal treated livers, indicating a
disruption in IFNc signaling. Accordingly, overexpression of A20
reduced the mRNA levels of the IFNc-target gene, UbiquitinD
(UBD)/FAT10 in rAd.A20, as opposed to rAd.bgal treated livers,
as demonstrated by qPCR (Fig. 6A). UBD/FAT10 is a ubiquitin-
like molecule that could be involved in post-translational
modifications of proteins, and hence may further add to the
ubiquitin-editing function of A20 [35,36].
Discussion
Liver regeneration is a physiologic repair mechanism that
occurs following liver damage as a result of toxic, viral, metabolic,
or ischemic insults, or after liver resection for tumor or living
donation. When liver regeneration is impaired, liver failure ensues
leading to significant morbidity or even death, unless the patients
undergo liver transplantation. Accordingly, defining the molecular
basis of liver regeneration could be instrumental in unveiling novel
therapeutic tools to optimize this process in the clinical setting.
We have identified A20 as a potent hepatoprotective protein that
is part of the physiologic anti-apoptotic, anti-inflammatory and
regenerative response of the liver [11,21,23,37]. Overexpression of
A20 in the liver afforded a significant survival and functional
advantage in mouse models of extreme liver injury and resection. In
patients undergoing living donor liver transplantation (LDLT),
expression of A20 also significantly increased 1 hour after
reperfusion, as determined by gene microarray analysis, validating
thefactthatA20ispartoftheregenerativeresponseinhumans[20].
Based on the above, we engaged in this study to clarify the effect of
A20 overexpression on the transcriptome in an extended LR model.
Extended LR is plagued with increased lethality as a result of ‘‘small
for size’’ remnant liver mass, and hence best reproduces massive
liver resections in patients with large tumors, or small for size liver
grafts, as sometimes seen following LDLT [38].
Even if does not establish a dose-effect relationship between A20
and the different target genes identified this microarray-based
analysis of the transcriptome in livers before and 24 hours after
78% LR, provided insight into the global transcriptional network
that was directly or indirectly affected by overexpression of A20.
Indeed, we demonstrated that A20 targeted multiple pathways
that were, as expected, central to cell cycle and immune and
inflammatory responses of the liver, but also unraveled novel
pathways impacted by A20 such as oxidoreductase balance, and
biosynthetic and metabolic liver processes. Systems Biology based
analysis of the data allowed for the first time to depict a global
picture of the regenerative process and its interactive pathways,
and to highlight the central nodes affected by A20 overexpression,
when compared to liver regeneration signature, as recently
determined in Dr. Karp’s study in mice[30]. Interestingly, our
data analysis also demonstrated that the effect of A20 preceded the
resection, further highlighting the impact of A20 on the liver
transcriptome, independently from the changes in gene profile that
are triggered by LR.
This approach stressed the effect of A20 overexpression in
hepatocytes upon optimizing and enhancing lipid metabolism, in a
way that is likely to increase energy production, hence providing
extra fuel to support the regenerative response. This outcome is
ideal, as it relieves the need to shunt energy away from other
cellular activities, namely the synthetic function of hepatocytes,
and hence avoids the usual impairment of the liver metabolic
functions when the organ is engaged in extensive proliferation.
Remarkably, most of the effects of A20 on these pathways were
present at baseline, and maintained following LR, indicating that
A20 overexpressing livers were prepared to face a greater
challenge than their control counterparts that require some time
before mounting a regulatory response to resection.
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inflammation and inflammatory signaling in the liver, as expected
for a NF-kB-inhibitory protein [19,29,39].
The other most notable pathway that was obviated by our
analysis relates to the significant impact that A20 had on cell cycle
in hepatocytes. A thorough mining of the data demonstrated that
overexpression of A20 led to a significant down-regulation of the
universal inhibitor of Cyclin/CDK activity, CDKN1A/p21,
before and after 78% LR. CDKN1A plays an important role in
regulating hepatocyte cell cycle progression and exit during
morphogenesis, differentiation, and repair [40,41,42]. The precise
regulation of p21 expression is mandatory for synchronization of
the first wave of hepatocyte proliferation following resection [43].
This has been clearly demonstrated in p21 knockout mice that
show accelerated hepatocyte proliferation following LR [44].
Therefore, reduced levels of p21 in A20 over-expressing livers
positions hepatocytes in a ‘‘pre-primed’’ state, engaging them in an
accelerated response to the proliferative stimuli triggered by LR.
Lipid metabolism was another pathway that was significantly
impacted by A20. It is well established that mobilization of
peripheral fat, hepatic FA uptake, and rapid accumulation of
intracellular triglycerides in hepatocytes are important for optimal
liver regeneration [45,46]. Cytokine signals after liver injury or LR
promote the release of FA into the circulation and their uptake by
hepatocytes [47]. As a result, lipid droplets form in hepatocytes
during the early stages of liver regeneration, providing energy to
fuel the proliferative response. Even though this transient steatosis
is part of the physiologic proliferative response, when excessive or
uncontrolled, it can impair liver regeneration [48,49]. Several
signals and molecules contribute to lipid accumulation during the
regenerative process including Leptin signaling [50], hepatic
Glucocorticoid-Receptor signaling, and Caveolin-1[51,52]. Our
results show no evidence for A20 affecting the expression of
Caveolin-1 or the Glucocorticoid-receptor complex, but obviates
that overexpression of A20 significantly inhibits the up-regulation
of the Leptin-receptor following 78% LR (31-339, Suppl. Table 2).
This points to an intriguing regulation of this system by A20 and
supports the hypothesis of Newberry et al and Leclercq et al, that
Leptin signaling per se is not directly involved in liver regeneration,
but rather required to promote the inflammatory and priming
response, following PH [50,53]. Accordingly, when the priming
response and the energy stores are already amplified by A20, we
surmise that upregulation of the Leptin receptor is no longer
required.
Besides priming, allocation of energy is the second crucial step
for the hepatocyte before entering cell cycle. Proliferating
hepatocytes require triglycerides as an energy source [54,55].
Generation of ATP form triglycerides relies on mitochondrial b-
oxidation as well as microsomal omega-oxidation of FA. One of
the main regulators of this process is PPARa, a central node
affected by A20 in our system. PPARa, a member of the nuclear
receptor superfamily, is a key player in the liver’s response to
metabolic dysregulation, inflammation, injury and resection [56].
Accordingly, PPARa knockout mice have impaired liver regener-
ation[14]. Our data demonstrates a significant increase in PPARa
and of its downstream target CPT1a expression before LR in livers
of A20 treated mice, indicating that A20 overexpressing livers are
pre-set to ramp-up their energy supply following LR, as to meet
increased demand of proliferating hepatocytes. This advantage
remained following 78% LR, as A20 expressing livers showed less
decrease in PPARa and CPT1a levels than bgal-treated livers. We
present strong evidence confirming this hypothesis by demon-
strating increased mitochondrial COX activity in A20 expressing
livers as opposed to controls, 24 hrs following 78% LR.
PPARa also enhances the degradation of lipid-derived inflam-
matory mediators by promoting b-oxidation i.e. ‘‘fat burning’’,
hence shunts these mediators away from the lipid peroxidation
(LPO) pathway, decreasing reactive oxygen species (ROS) burden
[47,56]. Decreased ROS in turn limits inflammation [57,58],
and protects hepatocytes from apoptosis [59,60], which adds to
the anti-inflammatory and anti-apoptotic function of A20 in
hepatocytes.
In addition, overexpression of A20 in the livers increased the
expression of the mitochondrial solute carriers DIC/SLC25a10
and Citrin/SLC25a13, which has the potential to further optimize
energy supply, and improve hepatocyte survival in A20-overex-
pressing livers [61,62].
Our data also demonstrated a profound decrease in IFNcsignal-
ing in A20 overexpressing livers. Whereas, most of the other
pathways that we evaluated were based on their implication in the
response to the procedure (i.e. surgical resection), the IFNc
pathway came up in our analysis probably because of the
adenoviral gene therapy vector we used [63]. Reduced IFNc
signaling in A20 overexpressing livers reflects the ability of A20 to
dampen the anti-viral immune response, which would be in
keeping with previous data demonstrating that A20 decreases anti-
viral responses [64].
Remarkably, the number of transcription factors upstream of
genes modified by A20 highlighted the impact of A20 on affecting
all NF-kB dependent genes, but also unraveled a number of other
transcription factors that were not so far identified as targets of
A20. These included E2F, CEBPA, EGR1, OCT4 and HNF1 that
were all over-represented in the promoter of genes impacted by
A20. Future work is aimed at determining whether A20 affects
directly or indirectly the activity of these transcription factors.
In summary, this Systems Biology-based analysis depicting the
impact of overexpression of A20 on liver function following
extended LR stresses the critical role of A20 in promoting liver
regeneration and function by optimizing energy production and
usage through improved lipid metabolism and down-regulation of
inflammation. In turn, this spares the need for energy consump-
tion involved in immune activation, therefore channeling the
supplies towards regenerative and metabolic functions of the liver.
Ongoing loss of function experiments using A20 +/2 mice totally
support this statement (Studer et al, manuscript in preparation).
Our results are particularly important in light of the recent
clinical validation of A20/tnfaip3 but also p21, SOCS3, and
PPARa, as part of the integral regenerative response of the liver in
the setting of LDLT [20], which supports our pursuit of A20-based
therapies to improve the outcomes of LDLT, marginal liver grafts,
and after extensive resections for tumor.
Materials and Methods
Ethics statement
The Institutional Animal Care and Use Committee of the Beth
Israel Deaconess Medical Center (BIDMC) approved all experi-
mental projects. All animal use is in compliance with all current
US government regulations concerning the care and use of
laboratory animals. There are no veterinary concerns related to
the use of mice as performed in this paper. Supervision of animal
care was conducted by staff members of a fully Association for
Assessment and Accreditation of Laboratory Animal Care
(AAALAC) accredited facility headed by Dr. Garibaldi. All
personnel handling the animals followed a specialized training
prior to starting. The BIDMC has been certified for Animal
Welfare Assurance. The number is A3153-01, expiring on 2/28/
2014. The approved protocol number is #064-2008.
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Recombinant adenoviruses (rAd.) encoding full length human
A20 or the control b-galacatosidase (bgal) were generated in our
laboratory, as previously described [65]. A20 or b-galactosidase
(bgal) gene expression in the mouse liver was achieved by penile
vein injection of 1x10
9 pfu of rAd. in 100 mL of normal saline,
which results in optimal transgene expression 5 days after injection
in 30% to 40% of hepatocytes [11].
Surgical model of liver resection
Extended (78%) LR, consisting of resection of the lateral,
medial, left, and right lobes, was performed 5 days following rAd.
administration in 8-week old BALB/c mice weighing 25 to 30
grams (Taconic, Germantown, NY), as described [11]. We took
extreme care to avoid blood loss and maintain euvolemia and
normal body temperature [11]. RNA was extracted from the
resected portion of the liver (before samples) and from the remnant
liver 24 hours after resection (after samples). Animals received care
according to the criteria outlined in the Guide for the Care and Use of
Laboratory Animals. All procedures were approved by the Institu-
tional Animal Care and Use Committee.
Data analysis
For transcriptional profiling, the mouse genome 430 2.0
Affymetrix GeneChip, containing more than 45,000 transcripts,
was used. RNA from three animals was pooled per microarray and
2 microarrays per group were analyzed. Microarray analysis was
conducted by the Genomics Center at the Beth Israel Deaconess
Medical Center according to previously described protocols for
total RNA extraction and purification, complementary DNA
(cDNA) synthesis, in vitro transcription for production of biotin-
labeled cRNA, hybridization of cRNA with mouse genome 430
2.0 Affymetrix gene chips, and scanning of image output files [66].
The raw gene expression data, in MIAME compliant format was
submitted to GEO database at NCBI for public access
(GSE24203). The quality of scanned arrays images were
determined on the basis of background values, percent present
calls, scaling factors, and 39–59 ratio of bactin and GAPDH using
the simpleaffy package for R [30].
Scanned array images were analyzed by dChip. The raw
probe level data was normalized using smoothing-spline
invariant set method and the signal value for each transcript
was summarized using the PM-only based signal modeling
algorithm in which the signal value corresponds to the absolute
level of expression of a transcript [25]. Normalized and modeled
signal values for each transcript were used for all further high-
level bioinformatics analysis. During the calculation of model
based expression signal values, array and probe outliers were
interrogated and image spikes were treated as signal outliers.
The outlier detection was carried out using dChip outlier
detection algorithm. A chip was considered to be an outlier if the
probe, single or array outlier percentage exceeded a default
threshold of 5%. To compare probe expression values, 90%
lower confidence bound (LCB) of the fold change (FC) was
calculated using dChip.
Informative genes
A set of informative genes was initially created from the union of
probes with an absolute expression $ 40 and LCB $1.5 for each
of the following sample comparisons: rAd. bgal after LR (post-
bgal) vs. rAd. bgal before LR (pre-bgal); rAd.A20 after LR (post-
A20) vs. rAd.A20 before LR (pre-A20), rAd.A20 before LR (pre-
A20) vs. rAd. bgal before LR (pre-bgal), or rAd.A20 after LR
(post-A20) vs. rAd.bgal after LR (post-bgal). The before and after
comparisons identify genes differentially affected by A20, while the
A20 and bgal comparisons identify genes differentially affected by
extended LR. To focus on the effect of A20, subsequent analysis,
was limited to genes that met the following criteria: after LCB $
1.5 or before LCB $ 1.5 or (A20 LCB $ 1.5 and bgal LCB no $
1.5). In order to quantify the effect of A20 on gene expression, we
calculated an interacting score using Equation 1:
Yi = (rAd.A20pre,i 2 rAd. bgal pre, i) + (rAd.A20 post, i 2 rAd.
bgal post, i). EQ 1
Where Yi is interaction score for each transcript generated using
the log2 transformed expression of each transcript in before (pre,i)
and after (post,i) resection conditions.
This equation captures the effects of A20 on baseline gene
expression as well as on the genes differentially affected by liver
resection; i.e. genes with the absolute highest scores affected the
most by A20 overexpression. We reduced the list of differentially
expressed probes to unique genes by selecting for the probe set
with the largest absolute interacting score among all the probe sets
mapping to the same Entrez ID using the BioConductor package
Genefilter [52,54,67].
Self Organizing Maps (SOM)
In order to identify gene expression profiles that are functionally
related to the biological state of interest, we performed SOM
clustering on transcript expression values using Pearson correla-
tion coefficient based distance metrics and a target of 100 groups.
SOM allow the grouping of gene expression patterns into an
imposed structure in which adjacent clusters are related, thereby
identifying sets of genes that follow certain expression patterns
across different conditions [68].
Enrichment, pathway, and network analysis
In order to identify over-represented gene ontology categories
from the informative set of genes, we used the Cytoscape plugin
BiNGO [12,26,27]. BiNGO maps the functions impacted by a
given gene set on the GO hierarchy and outputs this mapping as a
Cytoscape graph that assists in understanding biological theme.
The mouse genome was used as the background set of genes and
P-value correction was performed by the method of Benjamani
and Hochberg [69]. Additionally for analyzing enrichment in
SOM clusters, we used the Database for Annotation, Visualization
and Integrated Discovery (DAVID) [6,55].
We analyzed interactive networks and pathways using the
commercial system biology oriented package Ingenuity Pathways
Analysis (IPA 4.0) (http://www.ingenuity.com/). The knowledge
base of this software consists of ontology and network models
derived by systematically exploring the peer reviewed scientific
literature. It calculates the P value for each network, and pathway
according to the fit of user’s data to IPA database. It displays the
results as score (-log P value) indicating the likelihood of a gene to
be found in a network or pathways by random chance. For
example, a network achieving a score of 2 has at least 99%
confidence of not being generated by chance alone.
Promoter analysis
We performed promoter analysis using the online tool ExPlain
3.0 (http://explain.biobase-international.com/) for detection of
over-represented transcription factor binding sites. ExPlain uses
MatchTM, a weight matrix-based tool for searching putative
transcription factor binding sites [42,49]. For the analysis we
selected regions between 2000 bp upstream to 100 bp down-
stream of the transcription start site of each gene (Yes set) that
were conserved between human, mouse, and rat. The enrichment
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mouse housekeeping genes (No set). We used the entire vertebrate
non-redundant set of transcription factors matrix from transfac
database in scanning for potential binding sites [70]. In addition to
promoter analysis, we used the exPlain package to identify the key
‘‘upstream’’ signaling molecules that account for the observed
gene expression profile.
Quantitative Real Time PCR
cDNA was prepared using the iScript cDNA Synthesis Kit
(BioRad USA, Hercules, California). Quantitative PCR reactions
were prepared in duplicate using iTaq Fast SYBR Green
Supermix With ROX (BioRad) and gene specific primers (Table
S1). qPCR was performed on a 7500 Fast Real-Time PCR System
(Applied Biosystems, Foster City, California). b-actin was used as
an internal housekeeping reference. Gene expression was
quantified using the relative quantification method of Livak [71].
We analyzed qPCR results by both one- and two-way ANOVA
(Prism 5.0, GraphPad Software, La Jolla, California) for matched
pairs, when possible.
In vitro hypoxia/reoxygenation experiments
Rat primary hepatocytes were purchased from Cambrex
(Lonza, Walkersville, Maryland) and cultured at 37uCi n5 %
CO2 according to the supplier specifications. Cells were
transduced with rAd.A20 or the control rAd. bgal at a multiplicity
of infection of 100, which achieves transgene expression in .95%
of cells at 48 hrs with minimal toxicity. At 48 hrs after
transduction cells were subjected to 60 min of hypoxia at 1%
O2, followed by incubation under normoxic conditions for
120 min. Protein lystates were then extracted and immunodetec-
tion of carbonyl groups was performed by OxyBlot (Millipore,
Billerica, Massachusetts).
Enzymatic histology method for detection of
Cytochrome c Oxidase (COX, mitochondrial complex IV)
activity in liver tissues
COX couples the transfer of electrons from reduced cyto-
chrome c to oxygen, and is a good biomarker for the
bioenergetics function of the mitochondria. In brief, snap frozen
tissue sections from saline, rAd.A20 and rAd. bgal transduced
livers are treated with an incubation mediun (5 mg of the electron
donor 3–39 diaminobenzidine tetrahydrochloride (DAB), 10 mg
of cytochrome c and 20 mg of catalase in 10 ml of phosphate
buffer, pH 7.4) for 15 min. in a humidity chamber at 37uC. This
was followed by rinsing, counterstaining with hematoxylin,
ethanol dehydration and Xylene treatment. In this context
DAB produces an insoluble brown product that reflects the
function of complex IV. This method has shown excellent
mitochondrial specificity in several tissues including skeletal
muscle and liver[72]. Intensity of the brown staining per section
was scored by two investigators blinded to the study. Scores
ranged from 1 to 4 from fainter to stronger. Significance between
groups was analyzed by ANOVA.
Immunohistochemistry
Tissue samples from rAd.A20 and rAd. bgal treated livers were
recovered before and 48 hrs after extended LR, and fixed in 10%
buffered formalin. Five mm sections were immunostained with
Ki67 (Dako, Glostrup, Denmark) and anti-p21
waf1 (BD Bioscienc-
es, San Jose, CA) antibodies. Ki67 and p21 positive cells were
counted from 3 high power fields (hpf) per mouse liver by two
investigators blinded to the study.
Supporting Information
Figure S1 Expression of the transgenes in rAd.tran-
duced livers and time table protocol. A) Expression of
human A20 and nuclear E. Coli b-galactosidase in all mouse livers
used for microarray analysis was verified by qPCR, and by Xgal
staining for the bgalactosidase transgene in mouse livers 5 days
following rAd. iv injections. B) Protocol of transgene delivery prior
to liver resection in mice.
(TIF)
Figure S2 Principal component analysis of transcrip-
tional data. Open and filled blue and red circles represent
control (rAd. bgal) and rAd.A20 arrays respectively. The first
principal component with highest variation (47%) is shown on the
X-axis and separates the arrays on the basis of resection status
(before and after resection). The second component with median
variance (26%) is displayed on the Y-axis and separates the arrays
on the basis of the treatment (rAd. bgal vs. rAd.A20 arrays). An
inset with overall correlation of the arrays is also shown as a
dendrogram. The clustering depicts two major clusters on the basis
of resection status.
(TIF)
Figure S3 Hierarchical map of significantly enriched
Gene Ontology (GO) categories including biological
processes, molecular functions and cellular components
affected by A20 overexpression. (A) GO categories that are
significantly affected are shown by pseudocolor shading within the
hierarchical tree of GO classification. Each node corresponds to
one GO category. Each Branch starts with a general category and
divides stepwise into more specific categories. Highlighted regions
within the hierarchical tree represent significantly affected groups
of GO Categories, namely [I] cell cycle, [II] regulatory processes,
[III] immune responses, (IV) molecular functions related to
oxidoreductase, electron carrier activity, and oxidation-reduction
processes, V) cellular components (details not shown), and VI)
metabolic processes involved in amino acid, fatty acid, steroid,
lipid, and cholesterol biosynthesis. The number of genes in each
node is reflected by the node size and statistical enrichment (P
value) using a pseudo color scale (Orange for highly enriched,
yellow for significantly enriched and white for no enrichment). P
values are derived from hypergeometric test adjusted using
Benjamini-Hochberg. The GO categories graph was prepared
using the Cytoscape plugin, BiNGO.
(TIF)
Figure S4 Network of molecular interactions based on
the set of 1,595 differentially expressed unique genes.
This network was derived by merging the top 15 networks that
were the most significantly affected by A20 overexpression. Key
nodes (shown in BOLD) are determined based on edge density,
and include the following molecules: CDKN1A (p21), RB1,
CDK2, CyclinA, PPARa, IFNc, and AP1. The intensity of the
node color indicates the degree of up-regulation (red), down-
regulation (green) or no effect (white).
(PDF)
Figure S5 Validation of the role of A20 in liver
regeneration by comparing with external transcription-
al data. The behavior of 93 liver regeneration signature genes
obtained from a previously published data set in mice were
evaluated in rAd.A20 and rAd. bgal treated livers. The heat map
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before and after resection groups in the seed set (regeneration
signature), the bgal and the A20 groups. The genes form four
major clusters (I-IV) that consist of genes with different expression
patterns. The columns represent the bgal, A20 and regeneration
signature sets and the rows represent the 93 genes that are
modified upon LR. Gene expression is shown with pseudocolor
scale (23 to 3) with red denoting high LCB (gene up regulation)
and green denoting low LCB (gene down regulation). B) Subset of
genes involved in regeneration that are upregulated by A20 even
prior to resection. C) Subset of genes involved in regeneration that
are down regulated by A20 even prior to resection.
(TIF)
Table S1 List of primers used in real-time PCR.
(PDF)
Table S2 List of 1,595 unique genes, whose expression
is uniquely affected by A20. The genes were identified in any
of following comparison: i) bgal after vs. before resection, ii) A20
after vs. before resection, iii) A20 before resection vs. bgal before
resection, or iv) A20 after resection vs. bgal after resection. The
gene list was divided in 15 sections on the basis of the Venn
diagram shown in Fig. S2. The table depicts the average
expression level of the gene in A20 before and after resection as
well as bgal before and after resection groups.
(PDF)
Table S3 Gene Ontology analysis of SOM patterns. This
analysis was performed using the Database for Annota-
tion, Visualization and Integrated Discovery (DAVID ) v6.7 and
gene ontology categories with multiple test (Holm–Bonferroni
method) corrected P value ,0.05 were considered significant.
(PDF)
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